Business Standard

Viral vaccines, vector platforms may become new growth areas: DRL chief

In a Q&A, the chairman of Dr Reddy's Laboratories dwells, among other things, on the draft R&D policy and the first-ever Global Innovation Summit of the pharma sector held last November

Dr Reddy’s Laboratories chairman Satish Reddy
Premium

Dr Reddy’s Laboratories chairman Satish Reddy

Sohini Das Mumbai
Living with the pandemic for two years has caused strategic shifts in business models that are here to stay. In an emailed interview with Sohini Das, chairman of Hyderabad based Dr Reddy’s Laboratories Satish Reddy outlines how the pharma industry came together globally to produce essential Covid-19 drugs, vaccines, sanitisers and other items. Moreover, ahead of the Union Budget, the industry has already made representations for creating a policy environment to encourage innovation. Edited excerpts:

The pandemic has caused significant shifts in the dynamics of the pharma industry. Your comments.

I think that after two years of living with the

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 21 2022 | 2:34 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com